Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | MTOR | P42345 | 1/20 | 0.41 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27631395 | 0.76 | MTOR (0.43) | RAB9AMTORGRM7CYP3A4ALOX15 | |
| SCHEMBL11034119 | 0.76 | MAOB (0.44) | MAOBRAB9ANPC1TDP1SMN1; SMN2 | |
| SCHEMBL27335145 | 0.75 | ALDH1A1 (0.44) | NPC1TSHRTDP1ALDH1A1LMNA | |
| SCHEMBL7514017 | 0.72 | NPC1 (0.44) | MAOBRAB9ANPC1CYP3A4TDP1 | |
| SCHEMBL7514022 | 0.72 | NPC1 (0.44) | MAOBRAB9ANPC1CYP3A4TDP1 | |
| SCHEMBL264894 | 0.71 | MAOB (0.55) | MAOBRAB9ACYP1A2NPC1TSHR | |
| SCHEMBL264895 | 0.71 | MAOB (0.55) | MAOBRAB9ACYP1A2NPC1TSHR | |
| SCHEMBL3848021 | 0.70 | CYP1A2 (0.55) | MAOBCYP1A2TDP1ALDH1A1LMNA | |
| SCHEMBL11878598 | 0.70 | CYP1A2 (0.55) | MAOBCYP1A2TDP1ALDH1A1LMNA | |
| SCHEMBL2074728 | 0.70 | EPHX1 (0.48) | RAB9AMTORGRM7CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0758250-A1 | TEXAPHYRIN SOLID-SUPPORTS AND DEVICES | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1997-02-19 | — | — | EP | claimed |
| US-5594136-A | USEFUL IN THE SEPARATION OF NEUTRAL AND ANIONIC SPECIES, PHOSPHATE ESTER HYDROLYSIS, MAGNETIC RESONANCE IMAGING AND PHOTODYNAMIC THERAPY | PHARMACYCLICS, INC. (US) | 1997-01-14 | — | — | US | claimed |
| WO-1995029702-A1 | TEXAPHYRIN SOLID-SUPPORTS AND DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1995-11-09 | — | — | WO | claimed |
| JP-59186947-A | — | — | None | — | — | JP | disclosed |
| CN-103384707-B | The concentrated antiseptic composition of the stable water-based of dehydroacetic acid (DHA) (DHA) and methylisothiazolinone (MIT) | ISP INVESTMENTS INC. (US) | 2015-12-09 | — | — | CN | disclosed |
| CN-102686565-B | Hepatitis c virus inhibitors | BRISTOL-MYERS SQUIBB CO. (CH) | 2015-09-30 | — | — | CN | disclosed |
| CN-102741242-B | Hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2015-07-01 | — | — | CN | disclosed |
| CN-104302649-A | Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use | LEXICON PHARMACEUTICALS INC | 2015-01-21 | — | — | CN | disclosed |
| CN-103384707-A | A stable and aqueous concentrated preservative composition of dehydroacetic acid (DHA) and methylisothiazolinone (MIT) | ISP INVESTMENTS INC | 2013-11-06 | — | — | CN | disclosed |
| CN-103333162-A | Viral polymerase inhibitors | BOEHRINGER INGELHEIM INT | 2013-10-02 | — | — | CN | disclosed |
| CN-103319464-A | Viral polymerase inhibitors | BOEHRINGER INGELHEIM INT | 2013-09-25 | — | — | CN | disclosed |
| CN-1922174-A | Viral polymerase inhibitors | BOEHRINGER INGELHEIM INT (DE) | 2007-02-28 | — | — | CN | disclosed |
| WO-2005067665-A2 | ACTIVATABLE RIBOZYMAL PURIFICATION CONSTRUCTS AND METHODS OF USE | UNIVERSITY OF COLORADO (US) | 2005-07-28 | — | — | WO | disclosed |
| WO-2005037228-A2 | HALOGEN PHOSPHONATE MONOESTERS | INTEGRIGEN, INC. (US) | 2005-04-28 | — | — | WO | disclosed |
| EP-0758250-A1 | TEXAPHYRIN SOLID-SUPPORTS AND DEVICES | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1997-02-19 | — | — | EP | disclosed |
| US-5594136-A | USEFUL IN THE SEPARATION OF NEUTRAL AND ANIONIC SPECIES, PHOSPHATE ESTER HYDROLYSIS, MAGNETIC RESONANCE IMAGING AND PHOTODYNAMIC THERAPY | PHARMACYCLICS, INC. (US) | 1997-01-14 | — | — | US | disclosed |
| WO-1995029702-A1 | TEXAPHYRIN SOLID-SUPPORTS AND DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1995-11-09 | — | — | WO | disclosed |
| US-4487718-A | FOR HEMOSTATIC DISORDERS AND THROMBOSIS | KOWA COMPANY, LTD. (JP) | 1984-12-11 | — | — | US | disclosed |
| JP-S59186947-A | NOVEL PEPTIDE | KOWA CO | 1984-10-23 | — | — | JP | disclosed |
| EP-0121995-A2 | Peptides | KOWA COMPANY, LTD. (JP) | 1984-10-17 | — | — | EP | disclosed |